{"schema_version":"secwatch.filing_event.v1","accession":"0001575872-23-000606","form_type":"8-K","ticker":"ESLA","cik":"0001844417","company_name":"Estrella Immunopharma, Inc.","filed_at":"2023-04-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.158820+00:00","generated_at":"2026-06-16T19:30:32.664591+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"TradeUP Acquisition Corp. enters $50M common stock purchase agreement with White Lion Capital","bullets":["Up to $50M in common stock may be sold to White Lion at 97% of VWAP post-business combination with Estrella Biopharma.","Commitment fee of 250,000 shares of Estrella Series A Preferred Stock valued at $250,000 to be issued to White Lion.","Investor may terminate if registration statement lapses for 45 consecutive trading days or other material breaches.","Purchase price adjusts to 98% of VWAP after $25M of shares purchased.","Company must register shares for resale within 30 days of business combination."],"urls":{"canonical":"https://secwatch.observer/filing/0001575872-23-000606","json":"https://secwatch.observer/filing/0001575872-23-000606.json","markdown":"https://secwatch.observer/filing/0001575872-23-000606.md","text":"https://secwatch.observer/filing/0001575872-23-000606.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1844417/000157587223000606/0001575872-23-000606-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1844417/000157587223000606/uptd-20220419.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T19:30:32.664591+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c005181173542fd389610c859bd7cacf90dac887","claim":"Estrella Immunopharma, Inc. entered into Registration Rights Agreement with White Lion Capital, LLC (effective 2023-04-20).","evidence_excerpt":"Concurrently with the execution of the Common Stock Purchase Agreement, the Company entered into the RRA with the White Lion in which the Company has agreed to register with the SEC the shares of Common Stock purchased by White Lion under the Common Stock Purchase Agreement and the shares of Common Stock to be issued upon the conversion of Estrella Series A Preferred Stock for resale within 30 days of the consummation of the Business Combination.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1844417/000157587223000606/0001575872-23-000606-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"White Lion Capital, LLC"},{"label":"Effective","value":"2023-04-20"}],"fact_type":"material_agreement"},{"claim_id":"c30301b07ae09b7ea8f8afa47e53ffa83a41381d","claim":"Estrella Immunopharma, Inc. entered into Common Stock Purchase Agreement with White Lion Capital, LLC valued at up to $50,000,000 (effective 2023-04-20).","evidence_excerpt":"On April 20, 2023, TradeUP Acquisition Corp. (the “Company”) entered into a common stock purchase agreement (the “Common Stock Purchase Agreement”) and a related registration rights agreement (the “RRA”) with White Lion Capital, LLC, a Nevada limited liability company (“White Lion”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1844417/000157587223000606/0001575872-23-000606-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"White Lion Capital, LLC"},{"label":"Value","value":"up to $50,000,000"},{"label":"Effective","value":"2023-04-20"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}